Close

Advancing the use & generation of Real World Evidence across drug life cycle

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Upperton completes build of new £7m sterile manufacturing facility

Nottingham - Leading UK contract development and manufacturing organisation (CDMO)...

Oncology start-ups urged to apply and accelerate their business with Discovery Spark

Applications open for Discovery Park’s oncology themed ‘Discovery...

2025 AI Trends & Pharma Predictions

As we navigate what the future of healthcare will...

Real World Evidence is at the root of an ongoing and critical transformation in medical care. By incorporating data from the real-world into their development programs, drug developers are more than ever now able to drive more patient-facing outcomes, by supporting it with effective evidence-based decision-making across the product life cycle.

Our mission for the 7th IMPACCT: Real World Evidence meeting is simple: Build a collaborative forum that unites forward thinking industry leaders and innovators active in the RWE space for a comprehensive and open discussion on how to support and advance the generation and utilization of RWE across drug life cycle, from clinical R&D to commercialization.

Just some of our expert speakers already confirmed include:

  • Tony Hebden, VP, HEOR, AbbVie
  • Javier Jimenez, VP & Global Head of RWE & Clinical Outcomes, Sanofi
  • Danny Wiederkehr, Senior Director, Global HEOR Team, Pfizer
  • Sebastian Schneeweiss, Professor of Medicine & Epidemiology, Harvard Medical School
  • Melvin Olson, Global Head of RWD Strategy & Innovation, Novartis
  • Cathy Critchlow, VP, Center for Observational Research, Amgen
  • Keith Friend, Global Medical Director, Cardiovascular, Bristol-Myers Squibb
  • Mandeep Kaur, VP & Head of North America Medical Affairs for Immunology, Sanofi
  • John Graham, SVP, Medical Engagement & Value Evidence & Outcomes, GlaxoSmithKline
  • Michael Lees, Head of Value, Evidence & Portfolio, Takeda

Join the discussion alongside 80+ highly focused peers and leaders for exclusive insights that will inspire you to successfully drive patient-facing innovation across the product life-cycle.

Click here to see the full program and speaker line-up: http://bit.ly/2JeR4DE

We hope you can join us.

World Pharma Today readers receive an exclusive 10% discount to attend the forum. Simply quote VIP Code WPTPR10 at checkout to receive your discount.

We hope you’ll be able to join us.

The IMPACCT: Real World Evidence Team

Latest stories